Eddy L J, Oei H H, Glenn T M
Res Commun Chem Pathol Pharmacol. 1983 Jan;39(1):87-97.
Increased thromboxane A2 formation has been implicated in the pathophysiology of acute myocardial ischemia. The present study was designed to investigate the action of imidazole, a thromboxane synthetase inhibitor, during acute myocardial ischemia induced in anesthetized dogs. Regional ischemia was produced by ligation of the left anterior descending coronary artery (LAD), which caused a decrease in myocardial lactate extraction across the ischemic area, decreases in myocardial high energy phosphate contents and an increase in myocardial lactate in the center of the ischemic region. Intravenous administration of imidazole prior to LAD ligation attenuated the decrease in myocardial lactate extraction, but did not alter the depression in high energy phosphates or the rise in myocardial lactate content in the center of the ischemic myocardium. The results of this study support the suggested protective action of imidazole during an ischemic insult; perhaps by maintaining the metabolic status of the moderately ischemic border zone.
血栓素A2生成增加与急性心肌缺血的病理生理学有关。本研究旨在探讨血栓素合成酶抑制剂咪唑在麻醉犬急性心肌缺血过程中的作用。通过结扎左冠状动脉前降支(LAD)造成局部缺血,这导致缺血区域心肌乳酸摄取减少、心肌高能磷酸含量降低以及缺血区域中心心肌乳酸增加。在结扎LAD之前静脉注射咪唑可减轻心肌乳酸摄取的减少,但并未改变缺血心肌中心高能磷酸盐的降低或心肌乳酸含量的升高。本研究结果支持咪唑在缺血性损伤期间具有保护作用的观点;可能是通过维持中度缺血边缘区的代谢状态。